Antibiotic prescriptions and their uses
Patent Information
- Application Number
- LAP488
- Authority / Receiving Office
- LA · LA
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2026-01-16
AI Technical Summary
Existing antimicrobial preparations based on colloidal silver and polyhexamethylene guanidine derivatives face issues with stability upon freezing and thawing, sorption on water treatment filters, and low generation rates of silver ions, leading to reduced bactericidal activity and increased costs due to high silver concentrations.
The use of nanosized particles containing both silver and silver chloride, stabilized by amphoteric surfactants such as derivatives of ω-aminocarboxylic acids, which enhance the generation rate of silver ions, increase stability, and reduce sorption on filters, thereby improving bactericidal activity and reducing the required concentration of silver.
This approach results in a more effective and stable antiseptic preparation with increased bactericidal activity, allowing for lower concentrations of silver and reduced costs, while maintaining broad-spectrum antimicrobial efficacy and stability across various conditions.
Abstract
Description
[0001] ANTISEPTIC DRUG AND METHOD OF ITS USE
[0002] The invention relates to the field of sanitation and hygiene, in particular to antiseptic preparations, including disinfectants for disinfecting water in swimming pools and other artificial reservoirs, for the sanitary and hygienic treatment of premises, household equipment, furniture, household appliances and industrial equipment, as well as for disinfecting wash and waste water.
[0003] The prior art includes antimicrobial preparations for disinfecting water in swimming pools and other artificial reservoirs, as well as for the sanitary and hygienic treatment of premises and equipment.
[0004] US Patent No. 1993686, dated May 3, 1935, discloses a method for producing soap with antiseptic properties containing 0.5-1% by weight of “silver subchloride,” i.e., a substance with the formula Ag xCl, where x = 2. The proposed soap has bactericidal activity and does not change color when exposed to light. A disadvantage of this soap is its low antimicrobial efficacy and, as a result, its high silver content.
[0005] Russian Patent No. 2414912, dated March 27, 2011, discloses a disinfectant aqueous solution containing silver ions, distilled water, lactic acid, and a 33% aqueous hydrogen peroxide solution. This invention is intended for use in healthcare, the food and pharmaceutical industries, public utilities, for the disinfection and preservation of drinking water, and for the disinfection of swimming pools. A drawback of this product is the short duration of its biocidal action.
[0006] Russian patent application No. 2010134589 discloses a method for additional prolonged fungicidal disinfection of the surfaces of bathtubs and auxiliary areas of swimming pools. This method involves applying silver nanoparticles at a concentration of 167 ppm to the surface of ceramic tiles by treating the tiles with an aqueous-organic solution of nanosized silver particles for 40-50 hours at a temperature of 16-20°C, followed by rinsing with a hydrocarbon, a water-alcohol mixture, and distilled water for 30 minutes at room temperature. A disadvantage of this preparation is its insufficient biocidal effect. Furthermore, this multi-stage treatment method is quite complex. and labor-intensive.
[0007] Antimicrobial preparations based on polyhexamethylene guanidine salts are known from the prior art.
[0008] H-NHCNH(CH2) <H-
[0009] NH and also salts of polyhexamethylenebiganide
[0010] Russian Patent No. 2427380, dated August 27, 2011, discloses a disinfectant for treating skin containing colloidal silver, a polyhexamethylene guanidine salt, or a polyhexamethylene biguanide salt. This disinfectant exhibits high biocidal activity against Escherichia coli, Staphylococcus aureus, Leuconostoc mesenteroides, Aspergillus niger, and Saccharomyces cerevisiae. The minimum inhibitory concentration of the disinfectant disclosed in Russian Patent No. 2427380 against these strains is several times lower than the minimum inhibitory concentration of a similar disinfectant that does not contain colloidal silver. Based on the combination of its essential features, the disinfectant disclosed in Russian Patent No. 2427380 is the closest analogue to the claimed invention.
[0011] One of the main drawbacks of known antimicrobial agents based on colloidal silver and polyhexamethylene guanidine derivatives and the corresponding methods for using these agents is that positively charged silver particles stabilized by polyhexamethylene guanidine derivatives are easily adsorbed on water purification filters, especially those made from materials containing silicon oxide and aluminosilicates, as well as on pipes and pool walls. Furthermore, such agents lose stability during freezing and subsequent thawing. The rate of generation of silver ions, responsible for the bactericidal action of colloidal silver agents, during oxidative dissolution of silver particles is quite small, so to maintain a sufficient concentration of silver ions in water it is necessary to use high concentrations of colloidal silver.
[0012] In this regard, the task arises of increasing the effectiveness of silver-containing antiseptic preparations and the corresponding methods of their use, in particular: a) the task of increasing the stability of preparations by increasing their resistance to freezing and subsequent thawing; b) the task of reducing the degree of capture of preparations by water purification filters; c) the task of increasing the rate of generation of silver ions and, as a result, increasing the bactericidal activity of disinfectants.
[0013] The specified technical results are achieved by using an antiseptic preparation, described in more detail below.
[0014] Description of the invention
[0015] In an experimental study of the effect of various additives on the antimicrobial activity of colloidal silver preparations, it was found that nanosized particles containing both silver and silver chloride, including particles containing the non-stoichiometric compound Ag xCl, where x > 1, have higher antibacterial activity than similar nanosized silver particles Ag and nanosized silver chloride particles AgCl.
[0016] This is likely due to the fact that partial replacement of silver with silver chloride leads to an increased rate of silver ion generation due to the gradual dissolution of silver chloride. This allows for the use of a smaller amount of a nanoparticle-based product containing both silver and silver chloride compared to a product containing silver nanoparticles to achieve the required bactericidal efficacy. At the same time, the experimentally observed antimicrobial activity of colloidal solutions of nanosized silver chloride particles is lower than that of nanoparticle-based products containing both silver and silver chloride. This is primarily due to the fact that colloidal silver chloride solutions stabilized by low-molecular-weight compounds are prone to aggregation, especially when exposed to electrolytes found in biological environments.The surface area of nanoparticle conglomerates is significantly less than the total surface area of the particles that form them. The aggregation of silver chloride nanoparticles significantly reduces the rate of silver ion generation during particle dissolution, which is directly proportional to the particle surface area. Furthermore, silver chloride readily undergoes photolytic decomposition when exposed to light.
[0017] Thus, nanosized particles containing silver and silver chloride are characterized by: a) a high rate of generation of silver ions due to the presence of silver chloride in the composition, b) high aggregative stability characteristic of silver nanoparticles, and, as a consequence, c) pronounced antibacterial activity.
[0018] The use of nanosized particles that simultaneously include silver and silver chloride makes it possible, depending on the processing conditions and composition of the preparation, a) at a lower concentration of the active substance and, as a consequence, at a lower cost of the antiseptic preparation, to achieve the same or greater intensity of antimicrobial action as when using preparations based on nanosized particles of silver or silver chloride, b) to increase the intensity of antimicrobial action compared to the intensity of action of a colloidal solution of silver with the same cost of the preparation, c) to increase the intensity of antimicrobial action compared to the intensity of action of a colloidal solution of silver chloride with the same cost of the preparation.
[0019] In an experimental study of the effect of a stabilizer on the antimicrobial activity of preparations based on nanosized particles that simultaneously included silver and silver chloride, it was found that the highest aggregation stability is characteristic of preparations containing amphoteric surfactants (SAS) as a stabilizer, for example, derivatives of ω-aminocarboxylic acids and iminodicarboxylic acids, including N-alkyl-substituted derivatives of aminoacetic acid, 3-aminopropionic acid, iminodiacetic acid and iminodipropionic acid.
[0020] During experimental studies, it was found that such nanoparticles exhibit pronounced biocidal activity against many prokaryotic and eukaryotic microorganisms, including gram-positive and gram-negative bacteria and fungi. It was found that nanoparticles containing silver and silver chloride stabilized by amphoteric surfactants are stable over a wide pH range and are resistant to aggregation in the presence of electrolytes, which allows the use of dispersions of such nanoparticles as broad-spectrum antiseptics.
[0021] Nanoparticles containing silver and silver chloride stabilized by the tested amphoteric surfactants are negatively charged, which significantly hinders their adsorption on water purification filters with a similarly charged surface, particularly on filters made of materials containing silica and aluminosilicates. Furthermore, colloidal solutions of these nanoparticles retain their aggregative stability after repeated freezing and thawing.
[0022] Nanoparticles containing both silver and silver chloride can be obtained, for example, by partial oxidation of nanosized silver particles in the presence of chloride ions.
[0023] The claimed invention relates to an antiseptic preparation comprising nanosized particles containing both silver and silver chloride.
[0024] In a preferred embodiment of the invention, the antiseptic preparation additionally contains at least one amphoteric surfactant.
[0025] In a preferred embodiment of the invention, the concentration of the amphoteric surfactant in the antiseptic preparation is from 0.001 wt.% to 20 wt.%.
[0026] In a preferred embodiment of the invention, the concentration of nanosized silver particles in the antiseptic preparation is from 10 "4 mass% to 0.5 mass%.
[0027] In a preferred embodiment of the invention, the antiseptic preparation additionally contains auxiliary additives.
[0028] In a preferred embodiment of the invention, the auxiliary additives are selected from a group including acidity correctors, corrosion inhibitors, and thickeners.
[0029] In a preferred embodiment of the invention, at least one amphoteric surfactant is selected from the group, including carboxylic acids and their derivatives with the general formula
[0031] (type I compounds),
[0032] and carboxylic acids and their derivatives with the general formula
[0034] (type I compounds),
[0035] wherein the substituents Mi and M2 are selected from the group including H, Na, K, NH4, wherein the number a is 1 or 2, the number b is 2 or 3, the number c is 1 or 2, the number m is 1 or 2, the number u is 0 or greater than 0, the number p is 0 or greater than 0, the number q is greater than 0, wherein the substituent Ri is selected from the group including branched and unbranched saturated and unsaturated linear and cyclic hydrocarbon radicals.
[0036] In a preferred embodiment of the invention, at least one amphoteric surfactant is selected from the group consisting of -(2-ethylhexyl)-iminodipropionic acid and its salts, N-octyl-iminodipropionic acid and its salts, N-tallowalkyliminodipropionic acid and its salts, N-cocoalkyliminodipropionic acid and its salts, N-cocoalkylaminopropionic acid and its salts, a compound of type I in which K \is a cocoalkyl, M1 and M2-Na, a = 2, b = 3, c = 2, m = 2, n = 1, p = 0, a compound of type I in which R1 is cocoalkyl, M1 and M2-Na, a = 2, b = 2, c = 2, m = 2, n = 1, p = 0, a mixture of compounds of type I in which R1 is cocoalkyl, M1 and M2-Na, a = 1, b = , c = 1, m = 2, n is between 5 and 10, p = 0, a mixture of compounds of type I in which R1 is tallowalkyl, M1 and M2-Na, a = 1, b = , c = 1, m = 2, n is between 1 and 5, p = 0, a mixture of compounds of type I in which R1 is cocoalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 1 to 5, p is in the range from 7 to 10, compound of type I, in which Ri is cocoalkyl, Mi and M2 are Na, a = 2, b = 3, c = 2, m = 2, q = 1, p = 0, compound of type II, in in which Ri is cocoalkyl, Mi and M2-Na, a = 1, b = 2, c = 1, m = 1, q = 1, p = 0, a mixture of compounds of type II in which Ri is cocoalkyl, Mi and M2-Na, a = 1, b = 3, c = 1, m = 2, q is in the range from 5 to 10, p is in the range from 7 to 10.
[0037] The term "cocoalkyl" refers to a mixture of saturated and unsaturated hydrocarbon radicals, mainly C1-C2, which is part of the products obtained during the chemical processing of coconut oil.
[0038] The term "tallowalkyl" refers to a mixture of saturated and unsaturated hydrocarbon radicals, mainly C8-C 24 , which is part of the products obtained during the chemical processing of tall oil.
[0039] The claimed invention also relates to a method for disinfecting water, in which nanosized particles containing both silver and silver chloride are added to the water at least once.
[0040] In a preferred embodiment of the invention, at least one amphoteric surfactant is additionally added to the water.
[0041] In a preferred embodiment of the invention, at least one amphoteric surfactant is selected from the group comprising carboxylic acids and their derivatives with the general formula
[0043] (type I compounds),
[0044] and carboxylic acids and their derivatives with the general formula
[0046] (type II compounds),
[0047] wherein the substituents Mi and M2 are selected from the group including H, Na, K, NH4, wherein the number a is 1 or 2, the number b is 2 or 3, the number c is 1 or 2, the number m is 1 or 2, the number n is 0 or greater than 0, the number p is 0 or greater than 0, the number q is greater than 0, wherein the substituent Ri is selected from the group including branched and unbranched saturated and unsaturated linear and cyclic hydrocarbon radicals.
[0048] In a preferred embodiment of the invention, the at least one amphoteric surfactant is selected from the group consisting of N-(2-ethylhexyl)-iminodipropionic acid and its salts, N-octyl-iminodipropionic acid and its salts, N-tallowalkyliminodipropionic acid and its salts, N-cocoalkyliminodipropionic acid and its salts, N-cocoalkylaminopropionic acid and its salts, a compound of type I in which Ri is cocoalkyl, M1 and M2 is Na, = 2, b = 3, c = 2, m = 2, n = I, p = 0, a compound of type I in which Ri is cocoalkyl, ... \ and M2—Na, a = 2, b = 2, c = 2, m = 2, n = 1, p = 0, a mixture of compounds of type I, in which R \ is a cocoalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 5 to 10, p = 0, a mixture of compounds of type I in which R !is tallowalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 1 to 5, p = 0, a mixture of compounds of type I in which Ri is cocoalkyl, M1 and M2-Na, a = 1, ό = 3, c = 1, w = 2, n is in the range from 1 to 5, p is in the range from 7 to 10, a compound of type II in which Ri is cocoalkyl, M1 and M2-Na, a = 2, b = 3, c = 2, m = 2, q = 1, p = 0, a compound of type II in which Ri is cocoalkyl, M1 and M2-Na, a = 1, b = 2, c = 1, m = Ϊ, q = 1, p = 0, a mixture of compounds of type I in which Ri is cocoalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, t = 2, q is in the range from 5 to 10, p is in the range from 7 to 10.
[0049] In a preferred embodiment of the invention, auxiliary additives are additionally added to the water.
[0050] In a preferred embodiment of the invention, the auxiliary additives are selected from a group including acidity correctors, corrosion inhibitors, and thickeners.
[0051] The invention is illustrated by examples of alternative embodiments of its implementation.
[0052] Example 1
[0053] The antiseptic preparation used was a solution formed by partial oxidation of silver nanoparticles in a colloidal solution containing 0.03 wt.% of the amphoteric surfactant sodium N-cocoalkyliminodipropionate and 0.0025 wt.% of nanosized silver particles. Colloidal A silver solution was obtained using the method described in Russian Federation Patent No. 2,419,439 dated May 27, 2011, "Antibacterial Preparation and Method for Its Production," using a solution of the amphoteric surfactant sodium N-cocoalkylamine propionate instead of a cationic surfactant solution. An aqueous solution of silver acetate was added dropwise with stirring to the amphoteric surfactant solution. The resulting mixture was stirred for 15 min, after which an aqueous solution containing sodium borohydride NaBH4 and the amphoteric surfactant was added dropwise with stirring. After all the sodium borohydride had been added, the solution was stirred for 1 hour. A colloidal silver solution of an intense brown color was obtained. It was shown that during the synthesis process, silver salt is completely reduced by sodium orohydride to form nanosized silver particles.For partial oxidation of silver nanoparticles, a double excess of sodium chloride solution compared to the technometric amount was added to the obtained colloidal silver solution, and then, dropwise, with stirring, a solution of hydrogen peroxide with a concentration of 9 wt.% was added, while the solution gradually acquired an intense spun-polyethylene color.
[0054] The obtained antiseptic preparation A-1, unlike colloidal solutions of silver chloride, is stable in light and also exhibits aggregation stability over a long period of time. At the same time, the absorption spectrum of the obtained antiseptic preparation in the ultraviolet and visible regions differs significantly from the absorption spectrum of the original nanosized silver particles. The antiseptic preparation A-1 was studied using transmission electron microscopy. Amorphous nanoparticles were detected in the preparation sample; upon decomposition under the action of an electron beam, silver particles were formed. The appearance of silver particles during preparation decomposition was confirmed by electron microdiffraction data, since the diffraction rings in the microdiffraction pattern of the sample are located in the same way as in the microdiffraction pattern of a standard semicrystalline silver sample.The presence of silver chloride and silver in the nanoparticles of A-1 was confirmed using extended X-ray absorption fine structure (EXAFS) spectroscopy. Ag-Ag and Ag-Cl bonds were detected in a sample of coagulated nanoparticles of A-1, indicating that the nanoparticles contain both silver and silver chloride. 00615
[0055] Thus, in addition to sodium N-cocoalkylamine propionate, nanosized particles containing silver and silver chloride, and other reaction products, the antiseptic preparation A-1 contained water up to 100% by weight.
[0056] To evaluate the antibacterial activity of the drug against the gram-negative bacterium Escherichia coli ATCC 25922 and the gram-positive bacterium Staphylococcus aureus FDA 209P, as well as other bacteria, after incubating the cell suspension with a colloidal solution of nanoparticles for 1 hour at 30°C, samples of the suspension were taken and plated on solid agar medium in Petri dishes. The Petri dishes were incubated at 30°C for 24 hours, and the number of grown colonies was counted visually. The antibacterial activity of the control sample J4b 1, a stock solution of silver nanoparticles stabilized with sodium N-cocoalkyliminodipropionate, and the control sample J a 2, a colloidal solution of silver chloride containing 0.03 wt.% sodium N-cocoalkyliminodipropionate and 0.0025 wt.% silver chloride, were assessed in a similar manner.The control sample ΝΪ 2 was obtained by mixing stoichiometric amounts of silver nitrate and sodium chloride solutions, additionally containing sodium N-cocoalkyldimethylpropionate.
[0057] It was shown that in order to achieve the same antibacterial efficiency, it is necessary to add 2-2.5 times more control sample Hi 1 to the cell suspension than the proposed antiseptic preparation A-1. In addition, it was found that in order to achieve the same antibacterial efficiency, it is necessary to add 7-8 times more control sample Ni 2 to the cell suspension than the proposed antiseptic preparation A-1. It was also found that in order to achieve the same antibacterial efficiency, it is necessary to add 4-5 times more mixture of equal amounts of control sample Mi 1 and control sample Mi 2 to the cell suspension than the proposed antiseptic preparation A-1. This means that the antiseptic preparation based on nanoparticles including silver and silver chloride has a more pronounced biocidal activity than colloidal silver and colloidal silver chloride.This also means that when using nanoparticles containing silver and silver chloride, a synergistic effect of mutual enhancement of the bioactive activity of silver and silver chloride is observed. Thus, the proposed antiseptic product achieved the stated technical properties. The result is an increase in the biocide activity of the drug.
[0058] The resulting antiseptic product, A-1, was used to treat industrial and household equipment and inventory. The antiseptic effectiveness of the product was assessed based on the bacterial count of swabs from the treated objects. It was demonstrated that the resulting antiseptic product can be used for industrial and household disinfection. It can also be used for water disinfection. It was shown to have low toxicity to humans, is non-irritating to skin and mucous membranes, and exhibits no sensitizing, carcinogenic, mutagenic, or teratogenic effects.
[0059] Following toxicological studies, the resulting product was tested as an antiseptic for disinfecting water in swimming pools. A 10 m³ sauna pool was selected for testing. The pool had a standard recirculation system, including water discharge through a skimmer, filtration through a sand filter, and return of filtered water to the pool. Suspended particles were coagulated once a week by adding 60 g of aluminum sulfate. The pool was visited by 30-70 people per day. 6 liters of the resulting antiseptic product were added to the pool daily for a month, equivalent to 15 mg of nanoparticles containing both silver and silver chloride per 1 m³. 3water. The silver concentration in the pool water was determined daily by atomic absorption analysis using a Shimadzu AA-7000 atomic absorption spectrophotometer in accordance with the state standard of the Russian Federation GOST R 51309-99 "Drinking water. Determination of element content by atomic spectrometry methods." It was shown that the average silver content in the water was 4 mg / m3 ' \ which is associated with partial coagulation of particles of the preparation and their adsorption on the filter. Maintaining such a concentration of silver made it possible to achieve and maintain throughout the entire testing period the following values of indicators of bacterial contamination of water: total microbial count (TMC) - no more than 40 colony-forming units (CFU) per ml, total coliform bacteria TCB - absence, thermotolerant coliform bacteria TCB - absence, which indicates the high efficiency of water disinfection using the obtained antiseptic preparation. Thus, the obtained preparation can be used as an antiseptic for disinfecting water in swimming pools.
[0060] Example group 1
[0061] In the group of examples 1, antiseptic preparations were prepared similarly to example 1, while silver nitrate or acetate was reduced, while sodium N-cocoalkyliminodipropionate or sodium N-(2-ethylhexyl)-iminodipropionate, or sodium N-octyliminodipropionate, or sodium N-tallowalkyliminodipropionate, or sodium N-cocoalkylaminopropionate, or a compound of type I, in which Ri is cocoalkyl, Mi and M2 is Na, a = 2, b = 3, c = 2, m = 2, n = 1, p = 0, or a compound of type
[0062] I, in which R is cocoalkyl, M1 and M2-Na, a = 2, b = 2, c = 2, m = 2, n = 1, p = 0, or a mixture of compounds of type I in which R is cocoalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 5 to 10, p = 0, or a mixture of compounds of type I in which Ri is tallowalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 1 to 5, p = 0, or a mixture of compounds of type I in which Ri is cocoalkyl, M1 and M2-Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 1 to 5, p is in the range from 7 to 10, or a compound of type II in which Ri is cocoalkyl, M] and M2- Na, a = 2, b = 3, c = 2, m = 2, q = 1, p = 0, or a compound of the type
[0063] II, in which R] is cocoalkyl, Mj and M2 is Na, σ = 1, 6 = 2, c = 1, t = 1, q = 1, p = 0, or a mixture of compounds of type II, in which Rj is cocoalkyl, M1 and M2 is Na, a = 1, Ь = Ь, c = 1, t = 2, q is in the range from 5 to 10, p is in the range from 7 to 10. The concentration of the amphoteric surfactant was varied in the range from 0.001 wt.% to 20 wt.%, the concentration of nanosized silver particles was varied in the range from 10 "4 mass% to 0.5 mass%. In addition to the amphoteric surfactant, nanosized particles containing silver and silver chloride, and reaction products occurring during the synthesis of the drug, each resulting antiseptic drug contained water up to 100 mass%.
[0064] The efficacy of the obtained antiseptic preparations was assessed similarly to Example 1 against Escherichia coli, Staphylococcus aureus, Leuconostoc mesenteroides, Legionella pneumophila, Shigella spp., Pseudo onas aeruginosa, Salmonella enterica, Candida albicans, and Trichophyton spp. The obtained antiseptic preparations exhibited pronounced biocidal activity against the microorganisms used. In all cases, A technical result has been achieved, consisting of a statistically significant increase in the biocidal activity of the preparations in comparison with similar preparations based on nanosized silver particles and in comparison with similar preparations based on silver chloride.
[0065] The resulting antiseptic preparations were used to treat industrial and household equipment and inventory. The antiseptic effectiveness of the preparations was assessed based on the bacterial count of swabs from the treated objects. It was demonstrated that the resulting antiseptic preparations can be used for disinfection in both industrial and household settings. The resulting antiseptic preparations can also be used for water disinfection.
[0066] It was shown that the introduction of small amounts of chemically compatible auxiliary additives into the composition of the developed antiseptic preparations, in particular, acidity correctors, corrosion inhibitors, and thickeners, does not lead to a significant decrease in the biocidal activity of the preparations.
[0067] Those skilled in the art will recognize that many antiseptic formulations based on nanoparticles containing silver and silver chloride containing amphoteric surfactants not mentioned in the examples provided can be prepared and used similarly to the formulations described in the examples provided. Those skilled in the art will recognize that the claimed antiseptic formulations can, if appropriate, technically feasible, and legally permitted, be used to solve specific practical problems in the same way as other antiseptic formulations. Therefore, it is clear that the list of claimed uses for the antiseptic formulations does not limit the possible practical applications of the claimed antiseptic formulations.
Claims
CLAUSES OF THE INVENTION 1. An antiseptic preparation containing nanosized particles containing both silver and silver chloride.
2. An antiseptic preparation according to paragraph 1, characterized in that it additionally contains at least one amphoteric surfactant.
3. An antiseptic preparation according to claim 1, characterized in that at least one amphoteric surfactant is selected from the group comprising carboxylic acids and their derivatives of type I with the general formula (СН2)а—СООМ! Rj— (OSH2CH2)p- -N-(CH2)b-†NH2.m((CH2) -COOM2)m p and carboxylic acids and their derivatives of type II with the general formula (СН2)а—СООМ, About II Ri— (ОСН2СН2)р— С - •N-(CH2)b- ■NH2.m((CH2)c-COOM2)n wherein the substituents Mi and M2 are selected from the group including H, Na, K, NH4, wherein the number a is 1 or 2, the number b is 2 or 3, the number c is 1 or 2, the number m is 1 or 2, the number n is 0 or greater than 0, the number p is 0 or greater than 0, the number q is greater than 0, wherein the substituent Ri is selected from the group including branched and unbranched saturated and unsaturated linear and cyclic hydrocarbon radicals.
4. The antiseptic preparation according to claim 3, characterized in that at least one amphoteric surfactant is selected from the group consisting of N-(2-ethylhexyl)-iminodipropionic acid and its salts, N-octyl-iminodipropionic acid and its salts, N-tallowalkyliminodipropionic acid and its salts, N-cocoalkyliminodipropionic acid and its salts, N-cocoalkylaminopropionic acid and its salts, a compound of type I in which Ri is cocoalkyl, M1 and M2 is Na, a = 2, b = 3, c = 2, m = 2, n = 1, p = 0, a compound of type I in which Ri is cocoalkyl, M1 and M2 is Na, a = 2, b = 2, c = 2, m = 2, u = 1, p = 0, a mixture of compounds of type I in which Ri is cocoalkyl, Mi and M2 are Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 5 to 10, p = 0, a mixture of compounds of type I in which Ri is tallowalkyl, Mi and M2 are Na, a = 1, b = 3, c = 1, m = 2, n is in the range from 1 to 5, p = 0, a mixture of compounds of type I,in which Rj is cocoalkyl, M1 and M2 are Na, a = 1, 6 = 3, c = 1, M1 = 2, n is in the range from 1 to 5, p is in the range from 7 to 10, a compound of type II in which Ri is cocoalkyl, M1 and M2 are Na, a = 2, 6 = 3, c = 2, m = 2, q = \, p = 0, a compound of type I in which Ri is cocoalkyl, M1 and M2 are Na, a = 1, 6 = 2, c = \, m = \, q = 1, p = 0, a mixture of compounds of type I in which Ri is cocoalkyl, M1 and M2 are Na, a = 1, 6 = 3, c = 1, m = 2, q is in the range from 5 to 10, p is in the range from 7 to 10., 5. An antiseptic preparation according to paragraph 2, characterized in that the concentration of the amphoteric surfactant in the antiseptic preparation is from 0.001% by weight to 20% by weight.
6. An antiseptic preparation according to paragraph 1, characterized in that the concentration of nanosized silver particles in the antiseptic preparation is from 10"4 mass% to 0.5 mass%.
7. An antiseptic preparation according to paragraph 1, characterized in that it additionally contains auxiliary additives.
8. An antiseptic preparation according to paragraph 7, characterized in that the auxiliary additives are selected from a group including acidity correctors, corrosion inhibitors, and thickeners.
9. A method for disinfecting water in which nanosized particles containing both silver and silver chloride are added to water at least once.
10. The method for disinfecting water according to paragraph 9, characterized in that at least one amphoteric surfactant is additionally added to the water.
11. The method for disinfecting water according to claim 10, characterized in that at least one amphoteric surfactant is selected from the group comprising carboxylic acids and their derivatives of type I with the general formula (СН2)а— COOMi Ri— (OSH2CH2)p- -N-(CH2)b- -NH2.m((CH2) -COOM2)n -' η and carboxylic acids and their derivatives of type II with the general formula wherein the substituents Mi and M2 are selected from the group including H, Na, K, NH4, wherein the number a is 1 or 2, the number b is 2 or 3, the number c is 1 or 2, the number m is 1 or 2, the number u is 0 or greater than 0, the number p is 0 or greater than 0, the number q is greater than 0, wherein the substituent Ri is selected from the group including branched and unbranched saturated and unsaturated linear and cyclic hydrocarbon radicals.
12. The method for disinfecting water according to claim 11, characterized in that at least one amphoteric surfactant is selected from the group consisting of N-(2-ethylhexyl)-iminodipropionic acid and its salts, N-octyliminodipropionic acid and its salts, N-tallowalkyliminodipropionic acid and its salts, N-cocoalkyliminodipropionic acid and its salts, N-cocoalkylaminopropionic acid and its salts, a compound of type I in which Ri is cocoalkyl, Mi and M2 are Na, o = 2, b = 3, c = 2, m = 2, n = 1, ? = 0, a compound of type I in which Ri is cocoalkyl, Mi and M2 are Na, a = 2, b = 2, c = 2, m = 2, n = 1, p = 0, a mixture of compounds of type I in which Ri is cocoalkyl, Mi and M2 are Na, = 1, b = 3, c = 1, m = 2, n is in the range from 5 to 10, / 7 = 0, a mixture of compounds of type I in which Ri is tallowalkyl, Mi and M2 are Na, a = 1, b - , c = 1, m = 2, n is in the range from 1 to 5, p = 0, a mixture of compounds of type I,in which Rj is cocoalkyl, M1 and M2 are Na, a = 1, 6 = 3, c = 1, m = 2, n is in the range from 1 to 5, p is in the range from 7 to 10, a compound of type II in which Ri is cocoalkyl, M1 and M2 are Na, a = 2, b = 3, c = 2, m = 2, q = 1, p = 0, a compound of type I in which Ri is cocoalkyl, M1 and M2 are Na, a = 1, 6 = 2, c = 1, m = 1, q = 1, p = 0, a mixture of compounds of type II in which Rj is cocoalkyl, M1 and M2 are Na, a = 1, b = 3, c = 1, m = 2, q is in the range from 5 to 10, p is in the range from 7 to 10., 13. The method for disinfecting water according to paragraph 9, characterized in that auxiliary additives are additionally added to the water.
14. The method for disinfecting water according to paragraph 13, characterized in that the auxiliary additives are selected from a group including acidity correctors, corrosion inhibitors, and thickeners.
